Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
XPH
40
HOLDINGS
30%
ALSO IN PPH
PPH
26
HOLDINGS
52%
ALSO IN XPH
SECTOR DRIFT (XPH minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
PFIZER INC | 3.8% | 4.6% | 3.8% |
|
MERCK & CO. INC. | 3.8% | 5.9% | 3.8% |
|
JOHNSON & JOHNSON | 3.7% | 10.1% | 3.7% |
|
ELI LILLY & CO | 3.7% | 18.6% | 3.7% |
|
ZOETIS INC | 3.6% | 4.4% | 3.6% |
XPH Overweight Relative to PPH
|
ROYALTY PHARMA PLC CLASS A | 4.0% |
|
CORCEPT THERAPEUTICS INC | 3.9% |
|
TARSUS PHARMACEUTICALS, INC. | 3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 3.6% |
|
ORGANON & CO. | 3.6% |
 |
PERRIGO CO | 3.5% |
|
ELANCO ANIMAL HEALTH, INC. | 3.5% |
|
AXSOME THERAPEUTICS, INC. | 3.4% |
|
JAZZ PHARMACEUTICALS PLC | 3.2% |
|
VIATRIS, INC. | 3.2% |
XPH Underweight Relative to PPH
|
ELI LILLY & CO | -14.9% |
 |
NOVARTIS AG-ADR | -7.6% |
 |
NOVO-NORDISK A/S-SPONS ADR | -7.5% |
|
JOHNSON & JOHNSON | -6.3% |
|
MCKESSON CORP | -4.7% |
 |
SANOFI-AVENTIS-ADR | -4.5% |
|
ABBVIE INC | -4.4% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.3% |
|
CENCORA INC | -3.9% |